BDNF and Anxiety: We modelled this disease to test the hypothesis that CPA can ameliorate depressive-like behavior and anxiety induced by acute stress, associated with the augmentation of brain chemical transmitters, enhancement of the novel Nrf2-BDNF signaling pathway, and inhibition of biomarkers of oxidative stress and inflammation (Figure 1).